The results suggested that CXCL9/10/13 expressions were significantly associated with infiltrating levels of B cells, CD8+ T cells, CD4+ T cells, neutrophils, and DCs in breast cancer, while CXCL12 was conversely correlated with macrophages. Here, CD4 is linked to breast carcinoma.